MassBio is partnering with Otsuka on October 28 to host Otsuka Day 2026 at the MassBioHub, an afternoon of insights, discussion, and networking for biotech companies, investors, and members of the broader biotech community.
What they’re saying:
“At Otsuka, acquisitions and collaborations are an extension of our long-standing commitment to perseverance and clinical excellence. We partner with companies where we believe our expertise can help advance promising innovation and unlock more potential within Otsuka than they could on their own—ultimately maximizing the impact for patients worldwide.” – Tarek Rabah, CEO, Otsuka North America Pharmaceutical Business
Why it matters: Otsuka Day offers an opportunity to learn about Otsuka’s approach to external innovation through business development, strategic partnerships, and investing. Attendees will hear from senior Otsuka research and business development leaders as they discuss Otsuka’s partnering strategy, decision-making process, and experiences working with innovators across the biotech landscape.
What’s on the agenda:
- Opening Remarks & Introduction to Otsuka BioVentures with Tarek Rabah, CEO, Otsuka North America Pharmaceutical Business
- What is Otsuka Looking For? with Danny Abernathy, Search & Evaluation, Otsuka Business Development
- Panel Discussion: Many Parties, One Deal, an insider’s look at the complex journey of a biotech acquisition, from the first introduction through deal signing and closing, featuring Martin Buckland, Corporate Strategic Advisor and Consultant, Otsuka America, Inc.; Hannah England, Partner, Ropes & Gray; Owen Hughes, CEO, XOMA Royalty; Joanne Kotz, CEO, Atalanta; and Issi Rozen, General Partner, Google Ventures
- Fireside Chat: Turning the Deal Into Results, exploring what happens after an acquisition closes and how Otsuka preserves the entrepreneurial culture, scientific vision, and operational independence that drive innovation, with John Kraus, CMO, Otsuka Pharmaceutical Companies (U.S.); Zach Shriver, CEO, Visterra; and George Vratsanos, CEO, Jnana Therapeutics
The speaking program will close with a networking reception in the MassBioHub.
Who should attend: Otsuka Day is designed for biotech leaders and investors working in Otsuka’s core therapeutic areas:
- Neurology
- Psychiatry
- Immunology
- Nephrology
- Rare diseases
Whether you are building the next generation of therapies, investing in breakthrough science, or seeking strategic collaboration opportunities, Otsuka Day is designed to foster meaningful connections and advance innovative solutions for patients.
Be in the room: Apply to attend Otsuka Day 2026 here. Upon registering, you will receive a “pending approval” status. Your request will be reviewed, and you will receive a confirmation email once approved. This is a non-solicitation event.
